Northern Trust Corp Cel Sci Corp Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Cel Sci Corp stock. As of the latest transaction made, Northern Trust Corp holds 118,312 shares of CVM stock, worth $278,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,312

Previous 118,312 -0.0%

Holding current value

$278,033

Previous $47,000 42.55%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.11 - $1.85 $77 - $129	-70 Reduced 0.06%	118,312 $137,000
Q1 2024 May 14, 2024	BUY	$1.63 - $3.08 $56,264 - $106,315	34,518 Added 41.16%	118,382 $226,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $3.07 $6,023 - $17,281	5,629 Added 7.19%	83,864 $228,000
Q2 2023 Aug 11, 2023	SELL	$2.11 - $2.83 $3,348 - $4,491	-1,587 Reduced 1.99%	78,235 $188,000
Q1 2023 May 15, 2023	BUY	$2.17 - $3.13 $9,031 - $13,027	4,162 Added 5.5%	79,822 $185,000
Q2 2022 Aug 12, 2022	SELL	$2.58 - $4.99 $714,167 - $1.38 Million	-276,809 Reduced 78.53%	75,660 $340,000
Q1 2022 May 13, 2022	SELL	$3.93 - $7.7 $73,832 - $144,659	-18,787 Reduced 5.06%	352,469 $1.39 Million
Q4 2021 Feb 08, 2022	BUY	$7.1 - $12.82 $53,427 - $96,470	7,525 Added 2.07%	371,256 $2.64 Million
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $152,952 - $250,049	-20,020 Reduced 5.22%	363,731 $4 Million
Q2 2021 Aug 13, 2021	SELL	$8.68 - $27.49 $74,127 - $234,764	-8,540 Reduced 2.18%	383,751 $3.33 Million
Q1 2021 May 12, 2021	BUY	$12.0 - $27.64 $19,968 - $45,992	1,664 Added 0.43%	392,291 $5.97 Million
Q4 2020 Feb 11, 2021	SELL	$11.05 - $16.62 $87,748 - $131,979	-7,941 Reduced 1.99%	390,627 $4.56 Million
Q3 2020 Nov 16, 2020	SELL	$11.69 - $14.54 $112,563 - $140,005	-9,629 Reduced 2.36%	398,568 $5.08 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $132,444 - $239,078	13,584 Added 3.44%	408,197 $6.09 Million
Q1 2020 May 14, 2020	BUY	$7.54 - $17.05 $546,114 - $1.23 Million	72,429 Added 22.48%	394,613 $4.55 Million
Q4 2019 Feb 14, 2020	SELL	$6.71 - $9.55 $24,746 - $35,220	-3,688 Reduced 1.13%	322,184 $2.95 Million
Q3 2019 Nov 13, 2019	BUY	$6.0 - $9.6 $1.49 Million - $2.38 Million	247,629 Added 316.49%	325,872 $2.91 Million
Q2 2019 Aug 13, 2019	BUY	$3.77 - $8.67 $150,479 - $346,063	39,915 Added 104.14%	78,243 $656,000
Q3 2018 Nov 14, 2018	BUY	$0.83 - $4.16 $7,103 - $35,605	8,559 Added 28.75%	38,328 $155,000
Q2 2018 Aug 14, 2018	BUY	$0.92 - $3.5 $11,040 - $42,000	12,000 Added 67.53%	29,769 $27,000
Q1 2018 May 09, 2018	BUY	$1.38 - $2.33 $24,521 - $41,401	17,769 New	17,769 $25,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.55M

Call Options Held

73.8K

Put Options Held

106K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $102M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cel Sci Corp Transaction History